- Home
- CRSR vs PCRX Comparison
CRSR vs PCRX Comparison
Compare CRSR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRSR
- PCRX
- Stock Information
- Founded
- CRSR 1994
- PCRX 2006
- Country
- CRSR United States
- PCRX United States
- Employees
- CRSR N/A
- PCRX N/A
- Industry
- CRSR Computer Manufacturing
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- CRSR Technology
- PCRX Health Care
- Exchange
- CRSR Nasdaq
- PCRX Nasdaq
- Market Cap
- CRSR 698.8M
- PCRX 604.7M
- IPO Year
- CRSR 2020
- PCRX 2011
- Fundamental
- Price
- CRSR $6.70
- PCRX $16.52
- Analyst Decision
- CRSR Buy
- PCRX Buy
- Analyst Count
- CRSR 5
- PCRX 10
- Target Price
- CRSR $9.20
- PCRX $26.60
- AVG Volume (30 Days)
- CRSR 525.6K
- PCRX 545.3K
- Earning Date
- CRSR 11-06-2024
- PCRX 11-06-2024
- Dividend Yield
- CRSR N/A
- PCRX N/A
- EPS Growth
- CRSR N/A
- PCRX N/A
- EPS
- CRSR N/A
- PCRX N/A
- Revenue
- CRSR $1,320,042,000.00
- PCRX $694,957,000.00
- Revenue This Year
- CRSR N/A
- PCRX $4.59
- Revenue Next Year
- CRSR $13.57
- PCRX N/A
- P/E Ratio
- CRSR N/A
- PCRX N/A
- Revenue Growth
- CRSR N/A
- PCRX 4.40
- 52 Week Low
- CRSR $5.60
- PCRX $11.16
- 52 Week High
- CRSR $15.07
- PCRX $35.95
- Technical
- Relative Strength Index (RSI)
- CRSR 48.65
- PCRX 44.28
- Support Level
- CRSR $6.00
- PCRX $16.11
- Resistance Level
- CRSR $7.20
- PCRX $18.34
- Average True Range (ATR)
- CRSR 0.40
- PCRX 0.83
- MACD
- CRSR 0.01
- PCRX -0.17
- Stochastic Oscillator
- CRSR 54.69
- PCRX 5.33
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.